PRIMR PRIMR creates simple illustrated videos to educate patients about cancer and clinical trials.

Enhance clinical trial success with PRIMR’s patient-friendly video content.Simplifying trial information for all. 🎥✅http...
11/13/2025

Enhance clinical trial success with PRIMR’s patient-friendly video content.

Simplifying trial information for all. 🎥✅

https://www.primrmed.com/

11/12/2025

▶️ The Oncotype DX test analyzes the genes of your breast cancer to predict how aggressive it is and whether chemotherapy would help. It helps your doctor personalize your treatment so you can avoid unnecessary chemo if your cancer is less likely to return.

Learn more:
https://www.primrmed.com/cancer-education/oncotype-dx-for-breast-cancer

PRIMR empowers sponsors to navigate future engagement challenges in clinical trials. 🔍🌉https://www.primrmed.com/        ...
11/11/2025

PRIMR empowers sponsors to navigate future engagement challenges in clinical trials. 🔍🌉

https://www.primrmed.com/

11/10/2025

🎯 The RadiCaL Study tests whether adding Radium-223 to standard care reduces bone issues like pain or fractures in metastatic kidney cancer. This may offer better control of cancer that has spread to the bones.

makes trials accessible through watch-worthy content.

Learn more. Watch the IRB-approved video below:
https://www.primrmed.com/cancer-clinical-trials/kidney-cancer-trial-the-radical-study



Rana McKay | UC San Diego School of Medicine
Alliance for Clinical Trials in Oncology

  makes trials accessible through watch-worthy content.The RadiCaL Study tests whether adding Radium-223 to standard tre...
11/10/2025

makes trials accessible through watch-worthy content.

The RadiCaL Study tests whether adding Radium-223 to standard treatment can reduce bone-related complications in patients with metastatic kidney cancer.

Watch the IRB-approved video below:
https://www.primrmed.com/cancer-clinical-trials/kidney-cancer-trial-the-radical-study



Rana McKay | UC San Diego School of Medicine
Alliance for Clinical Trials in Oncology

Improve trial recruitment rates with PRIMR’s engaging video resources.Helping patients understand and participate confid...
11/06/2025

Improve trial recruitment rates with PRIMR’s engaging video resources.

Helping patients understand and participate confidently. 💡📊

https://www.primrmed.com/

11/05/2025

▶️ After breast cancer treatment, regular checkups and annual mammograms help track your recovery and catch early signs of recurrence. Follow-up exams, lifestyle habits, and open communication with your care team all play key roles in staying healthy long-term.

Learn more:
https://www.primrmed.com/cancer-education/breast-cancer-survivorship

PRIMR helps you anticipate and address patient engagement needs with precision. 🎥✅https://www.primrmed.com/
11/04/2025

PRIMR helps you anticipate and address patient engagement needs with precision. 🎥✅

https://www.primrmed.com/

11/03/2025

🎯 The RTIRE trial is testing whether targeting the most aggressive prostate tumors with electric pulses, followed by low-dose radiation, can control cancer while reducing urinary, bowel, and sexual side effects compared to standard treatments.

Watch the IRB-approved video below:
https://www.primrmed.com/cancer-clinical-trials/rtire-trial

gains quick approval with patient-centric submissions.



Timothy McClure | Weill Cornell Medicine

  gains quick approval with patient-centric submissions.The RTIRE trial studies whether targeting prostate cancer with e...
11/03/2025

gains quick approval with patient-centric submissions.

The RTIRE trial studies whether targeting prostate cancer with electric pulses (IRE) plus low-dose radiation can control tumors while reducing side effects.

Watch the IRB-approved video below:
https://www.primrmed.com/cancer-clinical-trials/rtire-trial



Timothy McClure | Weill Cornell Medicine

Address

Hartford, CT
06117

Alerts

Be the first to know and let us send you an email when PRIMR posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram